← Leaderboards
Scott C Bunce
Pennsylvania State Univ Hershey Med Ctr
$5,738,704
Attributed
$15,717,851
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.4M · FY2013–25$5M$3.8M$2.5M$1.3M$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,717,851 · 3
By mechanism
UH3$8,480,887 · 1
UG3$5,421,883 · 1
R01$1,815,081 · 1
Top collaborators
- Patricia Sue Grigson6 shared
- Roger Emil Meyer3 shared
- Timothy R. Brick2 shared
- Jennifer E. Nyland2 shared
Most similar at Pennsylvania State Univ Hershey Med Ctr
Same institution · by research overlap
- Patricia Sue Grigson$14,004,500
- Karam E El-Bayoumy$14,292,983
- Mark Kester$13,621,664
- Carla J. Gallagher$1,002,116
- Alexandros N Vgontzas$3,874,274
Others in their field
Top investigators on “Rattus”
- Barney Sparrow · Battelle Memorial Institute$76,162,078
- Reshan Fernando · Research Triangle Institute$42,714,061
- Boris Tabakoff · University Of Colorado Denver$35,561,072
- Yasmin L Hurd · Icahn School Of Medicine At Mount Sinai$35,063,410
- Milton D Hejtmancik · Battelle Centers/Pub Hlth Res & Evaluatn$34,625,987
- John Damon Chodera · Sloan-Kettering Inst Can Research$33,543,727
Research focus
RattusRelapsePharmaceutical PreparationsStressResponseAnimal ModelCuesMaleRewardsCravingResidential TreatmentBrainHeroinPilot ProjectsDoseOpioid Use DisorderMethadoneLiraglutideNaltrexoneCessation Of LifeAgonistBuprenorphineFemaleCaring
Grant awards (9)
Use of a GLP-1 Agonist to Treat Opioid Use Disorder in Rats and Man$4,444,024
UH3 · FY2025 · DA
Use of a GLP-1 Agonist to Treat Opioid Use Disorder in Rats and Man$4,036,863
UH3 · FY2024 · DA
Use of a GLP-1 Agonist to Treat Opioid Use Disorder in Rats and Man$145,779
UG3 · FY2021 · DA
Use of a GLP-1 Agonist to Treat Opioid Use Disorder in Rats and Man$2,557,628
UG3 · FY2020 · DA
Use of a GLP-1 Agonist to Treat Opioid Use Disorder in Rats and Man$351,281
UG3 · FY2020 · DA
Use of a GLP-1 Agonist to Treat Opioid Use Disorder in Rats and Man$2,367,195
UG3 · FY2019 · DA
Prescription Opioid Dependence Physiology Emotion and Treatment Outcome$603,189
R01 · FY2015 · DA
Prescription Opioid Dependence Physiology Emotion and Treatment Outcome$620,630
R01 · FY2014 · DA
Prescription Opioid Dependence Physiology Emotion and Treatment Outcome$591,262
R01 · FY2013 · DA